OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Colchicine in ischemic heart disease: the good, the bad and the ugly
Domenico D’Amario, Donato Cappetta, Luigi Cappannoli, et al.
Clinical Research in Cardiology (2021) Vol. 110, Iss. 10, pp. 1531-1542
Open Access | Times Cited: 36
Domenico D’Amario, Donato Cappetta, Luigi Cappannoli, et al.
Clinical Research in Cardiology (2021) Vol. 110, Iss. 10, pp. 1531-1542
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
The Role of Inflammation in Cardiovascular Disease
Michael Y. Henein, Sergio Vancheri, Giovanni Longo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12906-12906
Open Access | Times Cited: 314
Michael Y. Henein, Sergio Vancheri, Giovanni Longo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12906-12906
Open Access | Times Cited: 314
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Joel G. Rurik, Haig Aghajanian, Jonathan A. Epstein
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1766-1779
Open Access | Times Cited: 176
Joel G. Rurik, Haig Aghajanian, Jonathan A. Epstein
Circulation Research (2021) Vol. 128, Iss. 11, pp. 1766-1779
Open Access | Times Cited: 176
Immune cells in cardiac repair and regeneration
Filipa C. Simões, Paul R. Riley
Development (2022) Vol. 149, Iss. 8
Open Access | Times Cited: 30
Filipa C. Simões, Paul R. Riley
Development (2022) Vol. 149, Iss. 8
Open Access | Times Cited: 30
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial
Tjerk S.J. Opstal, Stefan M. Nidorf, Aernoud T.L. Fiolet, et al.
International Journal of Cardiology (2022) Vol. 372, pp. 1-5
Open Access | Times Cited: 21
Tjerk S.J. Opstal, Stefan M. Nidorf, Aernoud T.L. Fiolet, et al.
International Journal of Cardiology (2022) Vol. 372, pp. 1-5
Open Access | Times Cited: 21
The Role of Colchicine in Atherosclerosis: From Bench to Bedside
Leticia González, Juan Francisco Bulnes, María Paz Orellana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1395-1395
Open Access | Times Cited: 19
Leticia González, Juan Francisco Bulnes, María Paz Orellana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1395-1395
Open Access | Times Cited: 19
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence
Giovanni Cimmino, Francesco S. Loffredo, Gennaro De Rosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2483-2483
Open Access | Times Cited: 12
Giovanni Cimmino, Francesco S. Loffredo, Gennaro De Rosa, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2483-2483
Open Access | Times Cited: 12
Colchicin – Phönix aus der Asche
Raimund Lunzer, Georg Delle‐Karth, Markus Zeitlinger, et al.
Wiener klinische Wochenschrift (2025) Vol. 137, Iss. S1, pp. 1-33
Open Access
Raimund Lunzer, Georg Delle‐Karth, Markus Zeitlinger, et al.
Wiener klinische Wochenschrift (2025) Vol. 137, Iss. S1, pp. 1-33
Open Access
Inflammation, Lp(a) and cardiovascular mortality: results from the LURIC study
Stephanie Wissel, Hubert Scharnagl, Marcus E. Kleber, et al.
Clinical Research in Cardiology (2025)
Closed Access
Stephanie Wissel, Hubert Scharnagl, Marcus E. Kleber, et al.
Clinical Research in Cardiology (2025)
Closed Access
Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction
Chenyu Li, Donglu Qin, Jiarui Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Chenyu Li, Donglu Qin, Jiarui Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
The effect of immunomodulatory drugs on aortic stenosis: a Mendelian randomisation analysis
Jonathan Ciofani, Daniel Han, Milad Nazarzadeh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Jonathan Ciofani, Daniel Han, Milad Nazarzadeh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Precision Medicine in Acute Coronary Syndromes
Andrea Caffè, Francesco Maria Animati, Giulia Iannaccone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4569-4569
Open Access | Times Cited: 3
Andrea Caffè, Francesco Maria Animati, Giulia Iannaccone, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4569-4569
Open Access | Times Cited: 3
Antibacterial Activity and Antifungal Activity of Monomeric Alkaloids
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Toxins (2024) Vol. 16, Iss. 11, pp. 489-489
Open Access | Times Cited: 3
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Toxins (2024) Vol. 16, Iss. 11, pp. 489-489
Open Access | Times Cited: 3
Advances and Challenges in Biomarkers Use for Coronary Microvascular Dysfunction: From Bench to Clinical Practice
Erica Rocco, Maria Chiara Grimaldi, Alessandro Maino, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 2055-2055
Open Access | Times Cited: 15
Erica Rocco, Maria Chiara Grimaldi, Alessandro Maino, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 2055-2055
Open Access | Times Cited: 15
Colchicine treatment in amyotrophic lateral sclerosis: safety, biological and clinical effects in a randomized clinical trial
Giulia Gianferrari, Riccardo Cuoghi Costantini, V. Crippa, et al.
Brain Communications (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 2
Giulia Gianferrari, Riccardo Cuoghi Costantini, V. Crippa, et al.
Brain Communications (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 2
Colchicine for the secondary prevention of cardiovascular events
Fahim Ebrahimi, Julian Hirt, Christof Schönenberger, et al.
Cochrane library (2023) Vol. 2023, Iss. 8
Open Access | Times Cited: 4
Fahim Ebrahimi, Julian Hirt, Christof Schönenberger, et al.
Cochrane library (2023) Vol. 2023, Iss. 8
Open Access | Times Cited: 4
Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery
Rocco Vergallo, Leonarda Galiuto
European Heart Journal (2024)
Open Access | Times Cited: 1
Rocco Vergallo, Leonarda Galiuto
European Heart Journal (2024)
Open Access | Times Cited: 1
Editorial: Inflammation in ischemic heart disease: pathophysiology, biomarkers, and therapeutic implications
Luigi Cappannoli, Mattía Galli, Josip A. Borovac, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Luigi Cappannoli, Mattía Galli, Josip A. Borovac, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 1
2024 ESC Guidelines on Chronic Coronary Syndromes: What is New in Pharmacotherapy?
Mattía Galli, Felice Gragnano, Christiaan Vrints, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 7, pp. 572-574
Closed Access | Times Cited: 1
Mattía Galli, Felice Gragnano, Christiaan Vrints, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 7, pp. 572-574
Closed Access | Times Cited: 1
Clinical, Laboratory, and Electrocardiographic Findings in Colchicine Toxicity: 10 Years of Experience
Mehdi Sheibani, Nasim Zamani, Amir Gerami, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Mehdi Sheibani, Nasim Zamani, Amir Gerami, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 7
Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
Aldo Moggio, Heribert Schunkert, Thorsten Kessler, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15814-15814
Open Access | Times Cited: 6
Aldo Moggio, Heribert Schunkert, Thorsten Kessler, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 15814-15814
Open Access | Times Cited: 6
The therapeutic potential of sphingolipids for cardiovascular diseases
Sapir Ya’ar Bar, Noam Pintel, Hesen Abd Alghne, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Sapir Ya’ar Bar, Noam Pintel, Hesen Abd Alghne, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
New approaches to pathogenetic anti-inflammatory therapy of cardiovascular diseases
Е. П. Колесова, А. L. Maslyanskiy, О. P. Rotar, et al.
HERALD of North-Western State Medical University named after I I Mechnikov (2023) Vol. 15, Iss. 2, pp. 19-32
Open Access | Times Cited: 2
Е. П. Колесова, А. L. Maslyanskiy, О. P. Rotar, et al.
HERALD of North-Western State Medical University named after I I Mechnikov (2023) Vol. 15, Iss. 2, pp. 19-32
Open Access | Times Cited: 2
Regenerative loss in the animal kingdom as viewed from the mouse digit tip and heart
Fayth Hui Tan, Marianne Bronner‐Fraser
Developmental Biology (2023) Vol. 507, pp. 44-63
Closed Access | Times Cited: 2
Fayth Hui Tan, Marianne Bronner‐Fraser
Developmental Biology (2023) Vol. 507, pp. 44-63
Closed Access | Times Cited: 2
H19 is involved in the regulation of inflammatory responses in acute gouty arthritis by targeting miR-22-3p
Yan-Yan Xue, Huijie Liu, Zhan-Juan Sun, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 392-399
Closed Access | Times Cited: 4
Yan-Yan Xue, Huijie Liu, Zhan-Juan Sun, et al.
Immunologic Research (2022) Vol. 70, Iss. 3, pp. 392-399
Closed Access | Times Cited: 4
The Interrelationship between Sarcoidosis and Atherosclerosis—Complex Yet Rational
Sara Hoss, Tzlil Grinberg, Alon Eisen
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 433-433
Open Access | Times Cited: 3
Sara Hoss, Tzlil Grinberg, Alon Eisen
Journal of Clinical Medicine (2022) Vol. 11, Iss. 2, pp. 433-433
Open Access | Times Cited: 3
